Biotech and Pharmaceuticals
Supreme Court skeptical of effort to make abortion pill harder to obtain
Demonstrators gather in front of the Supreme Court as the court hears oral arguments in the case of the U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine on March 26, 2024 in Washington, DC. Anna Rose Layden | Getty Images News | Getty Images WASHINGTON — The Supreme Court on Tuesday appeared likely to reject […]
Read More
Moderna says new Covid vaccine showed stronger immune response than current shot in study
A nurse fills a syringe with Moderna Covid-19 vaccine. Fred Tanneau | Afp | Getty Images Moderna on Tuesday said a new version of its Covid vaccine triggered a stronger immune response against the virus than its current shot in a late-stage trial. The results come as Moderna competes with rival Pfizer for more share […]
Read More
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data
Alexey Krukovsky | Istock | Getty Images Viking Therapeutics shares jumped more than 15% on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year. The study results add to the excitement around the drugmaker’s prospects in […]
Read More
Supreme Court weighs challenge to abortion pill's widespread availability
Pedestrians walk in front of the U.S. Supreme Court February 29, 2024 in Washington, DC. Robert Nickelsberg | Getty Images The Supreme Court on Tuesday tackles whether to maintain widely available access to the abortion pill mifepristone as it weighs a high-stakes challenge to the Food and Drug Administration’s drug approval process. The court, which has a […]
Read More
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
The Amgen logo is displayed outside Amgen headquarters on May 17, 2023 in Thousand Oaks, California. Mario Tama | Getty Images Amgen is taking a new approach as it tries to stand out in a crowded field of drugmakers racing to develop the next blockbuster weight loss drug. The biotech company is testing an injectable […]
Read More
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Demand for weight loss drugs is booming in the U.S. despite their limited insurance coverage and roughly $1,000 monthly price tags before discounts. But some patients are willing to pay more out of […]
Read More
Medicare can now cover certain weight loss drugs in a big step for patients
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Medicare can start covering certain weight loss drugs for the first time – as long as they are approved for an added health benefit, the Centers for Medicare and Medicaid Services said Thursday. […]
Read More
FDA says safety issues with China-made syringes are 'more widespread' than previously known
Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration warned Tuesday that Chinese-made plastic syringes that are distributed in the U.S. have “more widespread” quality control issues than were previously known. In a safety communication, the […]
Read More
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for […]
Read More
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in popularity over the last year — is now approved in the U.S. for heart health, too. But that may not translate to wider insurance coverage of […]
Read More